News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

James M. Scheiman, MD

Articles by James M. Scheiman, MD

Use of Selective COX-2 Inhibitors for Chronic Therapy: The Managed Care Perspective

ByJames M. Scheiman, MD

November 1st 2002

Gastrointestinal Outcomes: Evidence for Risk Reduction in Patients Using Coxibs

ByJames M. Scheiman, MD

November 1st 2002

The Impact of Nonsteroidal Anti-Inflammatory Drug-Induces Gastropathy

ByJames M. Scheiman, MD

February 1st 2001

Latest Updated Articles

Use of Selective COX-2 Inhibitors for Chronic Therapy: The Managed Care Perspective
November 1st 2002
Gastrointestinal Outcomes: Evidence for Risk Reduction in Patients Using Coxibs
November 1st 2002
The Impact of Nonsteroidal Anti-Inflammatory Drug-Induces Gastropathy
February 1st 2001

Trending on AJMC

Multiagonists Outpace Older GLP-1 Drugs for Weight Loss

Evolocumab Cuts Death Risk for a First Heart Attack or Stroke

Cardiac Risks of COVID-19 Vaccine vs Infection: Eman Toraih, MD, PhD

FDA Approves Ropeginterferon Alfa-2b in Essential Thrombocythemia

NFL Dementia Deaths Often Miss Neurodegenerative Diagnosis